ClinicalTrials.Veeva

Menu

Side Effects After Direct-acting Antiviral Treatment (EFINO-C)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Completed

Conditions

Chronic Hepatitis c

Treatments

Drug: DAA treatment

Study type

Observational

Funder types

Other

Identifiers

NCT03346941
CRC_GHN_2017_004

Details and patient eligibility

About

The objective of this study was to assess the incidence of side effects after direct-acting antiviral therapy in patients with chronic hepatitis C virus infection.

Full description

Direct-acting antiviral (DAA)-based treatments are today very effective The objective of this study was to assess the incidence of side effects after DAA therapy in patients with chronic hepatitis C virus infection.

Enrollment

95 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 years of age or older
  • Hepatitis C virus infection
  • Treatment by direct-acting antiviral combination

Exclusion criteria

  • HIV coinfection

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems